Explore

Communities in English

Advertise on Engormix

vaccines against infectious laryngotracheitis virus

Forum: Attenuated vs. vector vaccines against infectious laryngotracheitis virus (ILTV)

Published: August 28, 2012
By: Grzegorz Wozniakowski

Infectious laryngotracheitis virus ILTV represents an important problem in production of chickens. The disease causes respiratory symptoms but also affects production of eggs, chicken body weight and finally mortality. As in case of other herpesviruses including Marek’s disease virus one of the most important aspect remains biosecurity. The most popular vaccination is based on attenuated ILTV strains (SA2 and A20, Pfizer) and (Serva, Intervet). However in some circumstances after serial passaging of the attenuated CEO (chicken embryo origin) strains on chickens the viruses may recover their virulence causing massive death of chickens. Moreover in 2008 the reports from Australia described the recombination event between virulent and attenuated ILTV strains that resulted mortality close to 18% of the flock. The solution for tomorrow are the new vector vaccines based of herpesvirus of turkey (HVT) or (FPV) fowl pox virus carring genes encoding viral glycoproteins gD, gI or gB. The main advantage of such vaccines application is the lack of viral transmission that overcomes the problem with the recombination between strains in chickens. Since these vaccines have been accessible in US I am curious about their efficacy in comparison to the live attenuated vaccines. Also the last results have shown that these vaccines are the most effective when in ovo route is applied vs. (ED) eye-drop or DW (drinking water) ways of application.

What is your experience using both live attenuated and vector vaccines based on HVT or FPV? All comments regarding your personal opinion of vaccination against ILT are highly appreciated.

Best regards,

Greg

Related topics:
Authors:
Grzegorz Wozniakowski
National Veterinary Research Institute (Poland)
Recommend
Comment
Share
Eric Gingerich
Diamond V
28 de agosto de 2012

The following are my experiences with egg layer chickens in the US: Good results have been seen with the rHVT-ILT vaccine to prevent early problems due to early exposure. In combination with either the CEO vaccine by eyedrop or the rPox-ILT vaccines, very good protection is seen over the long term. The rHVT-ILT by itself at day one by subQ will hold in moderate risk situations while the rPox-ILT vaccine by itself will only hold in very low risk conditions.

Recommend
Reply
Manolo Fernandez Diaz
Farvet
Farvet
29 de agosto de 2012

Interesting forum about Infectious laryngotracheitis virus. In Peru, the LT problem began in 2007, a comprehensive work of the health authority (SENASA), Poultry Farmers Association (APA) and private laboratories and state agreed to not using live vaccines for the control of LT.
We have had a remarkable success with a harmonic work between biosafety,using recombinant vaccines (HVT-IBD-LT, HVT-LT and FOWL POX- LT) and inactivated vaccines with adjuvants that stimulate the immune response at mucosal level.

Today in our lab we are working on the development of multi epitope vaccines

Recommend
Reply
Yasser Ahmed
27 de marzo de 2013

Dear Dr. Greg,

I already use this vaccine in many layer & broiler breeders farms as I was working in CEVA SANTE ANIMALE as a key account manager in KSA. This enabling me to study & notice the advantages of vector vaccine FP LT or FP LT AE vaccine. Yes, I agree with you that with this vector vaccine there is no way to virus recovering to return back to its virulence while on the other hand i saw how is attenuated traditional vaccine can cause virus recovering to be virulent & infect other birds which have lower immune level against ILT specially in multi-age layer farms as the virus transmitted from newly transmitted poults in production houses to older birds at neughbour houses (lower immunilty due to decline in AB after 20 weeks from vaccination with attenuated ILT vaccines) which give a chronic or mild form of ILT with moderate increase in mortality & slight decrease in production. Also i saw how much traditional attenuated vaccine has a role to transmite disease to broiler in winter season in EGYPT. This is one advantage enough to change mind towards ILT prevention while there are other advantages which are valuable like:

1- No post vaccinal reaction which in attenauted types cause respiratory manifestation which adversely affect growth & cause mortality and it needs antibiotic cost to overcome PVR .
2- with this vaccine you vaccinate against 2 or 3 diseases within one shot.
3- by using this vector vaccine specially in hot countries with strict hygeinic measures you can eradicate disease at local areas where there is no way for virus shedding beside character of ILT virus itself which are:

a- ILT virus are easily distructed by heat over 32 C
b- ILT strains have only one serotype (no variants)
c- ILT virus has only one host which is chicken so there is no carriers for ILT except chicken
while at the level of effectiveness it gave excellent results

Yasser HUSSEIN

Recommend
Reply
Manolo Fernandez Diaz
Farvet
Farvet
20 de mayo de 2013
Indeed the use of recombinant vaccines is the only alternative to eradication and control of avian laryngotracheitis. We are in the era of biotechnology, inactivated vaccines currently have enhanced with new adjuvants and recombinant proteins and obtained a very good protection against LT Manolo Fernandez
Recommend
Reply
Gary Butcher
University of Florida
University of Florida
23 de septiembre de 2013

Dear Dr. Greg,

I had worked with recombinant vaccines in my laboratory for over 10 years against a number of agents-- ILT, Gumboro, Newcastle, Marek's. These worked very well in the laboratory, giving complete protection against contolled challenge. However, in the field they were a disappointment in that small disease breaks consistently occurred. Recently in the state of Florida (USA), the recombinant ILT was used and these flocks broke with the disease. Since these vaccines worked very well in the laboratory and poorly in the field, it is clear that this is due to sanitary and vaccine application errors. I feel that if the poultry house is completely decontaminated of agents that would interfere with the replication of the vector virus, then these products will be successful.

My main problem at this time is that for a vaccine to be accepted it has to be at least as good in protecting as the currently available vaccines on the market and it has to be economical. I do not feel the ILT recombinant meets these critera at this time.

Gary Butcher

Recommend
Reply
Manolo Fernandez Diaz
Farvet
Farvet
23 de septiembre de 2013

The PERU is one of the few country in the world where LT control have Not been used live vaccines. The use of recombinant vaccines (HVT-LT, HVT-IBD-LT and FP-L) associated with LT inactivated vaccine have remarkable success in controlling LT.
The marketing system in PERU of broilers is 75% live (standing), and laying hens at the end of its production is sold for consumption 100% live in standing.
That shows if possible the LT control with recombinant vaccines and oil vaccines.
In Australia in July 2012 has been reported recombination of two commercial live vaccines in cell culture leading to a new highly pathogenic virus with mortalities more than 20%, this would not be possible in the control program of PERU

Recommend
Reply
Eric Gingerich
Diamond V
2 de octubre de 2013
In answer to Dr. Butcher's statement, please state which vaccine failed and what type of birds were involved. We have seen the pox vectored ILT vaccine fail badly in egg-type pullets in high challenge situations. The HVT vectored product has held up much better in egg-type pullets if the vaccine was properly applied at the hatchery and a second application of live vaccine or pox vectored ILT vaccine is given at 8 weeks. In broilers, none of the vectored ILT products applied inovo or day old has totally prevented outbreaks.
Recommend
Reply
Alvin C. Besagsa
3 de octubre de 2013
In our country, Ive been conducting serology among layer farm in northern Mindanao, farmers does not have ILT vaccination, but it turn outs positive in the ELISA test what does it mean, do i need to recommend vaccination against ILT, what is the best recombinant vaccine that is safe to use? and what is the normal titer level that we can say that, this titer level come from vaccination or from the field challenge? i need your comments plz.
Recommend
Reply
Eric Gingerich
Diamond V
3 de octubre de 2013
In my opinion, serology is not an accurate method to diagnose ILT. Clinical signs along with histopathologic lesions, positive PCR, or positive FAT should be used to determine if vaccination is needed. As far as safety, any of the recombinants are safe to use and will not result in ILT disease issues.
Recommend
Reply
Alvin C. Besagsa
3 de octubre de 2013
Clinical signs are the following 1. tears in the eye with seems and reddish in color 2.swollen face. 3.Upon necropsy some birds has hemorrhagic tracheal ring Blood stained trachea or even clotted blood was observed near the syrinx,this sign convince me conduct serology on ilt, and yet it turn out positive to mention, farm has high ammonia level since it is situated in poorly ventilated areas,this flock also has high antibody titer of ibv, that reaches 20,000+++, peak production is only at 85% please comment......
Recommend
Reply
Eric Gingerich
Diamond V
3 de octubre de 2013
IBV, Mg, ammonia, infectious coryza, Pasteurella, avian influenza, Newcastle can all produce the signs you describe. Antigen or pathogen detection tests need to be utilized to differentiate these diseases. For ILT diagnosis, one can also use histopathology. Finding intranuclear basophilic inclusion bodies in syncytia of the tracheal or brohchial epithelium is diagnostic for ILT.
Recommend
Reply
Aoun Khan
21 de octubre de 2013

I  think that a possible solution would be the use of tissue culture ILT Vaccination

Recommend
Reply
Dr. Mahadi Hasan
5 de abril de 2014

Dear Mr. Manolo,

Nice to meet with you, I got your contact address from your colleague Mr. Avi. I am Dr. Mahadi Hasan working in vaccine field and more interested in recombinant vaccine. I saw you discussion and know that your company can produce recombinant vaccine, I would like to work on your vaccine and interested to import your vaccine in our country. In Bangladesh there is a huge business opportunity, there is no local manufacturer and we are fully depends on import from other MNC companies but they can't meet the full demand. So there is a gap and also there is huge demand of this new technology. I believe I will capture the full market and give you good business with your best cooperation. So if you are interested please contact me.

Waiting for your quick and positive feedback.

Best Regards,

Dr. Mahadi Hasan
Dhaka, Bangladesh

Recommend
Reply
nosheen naheed
29 de noviembre de 2016

In my farm birds are producing voice like (garer) and sneezing. the age of broiler birds are10 days. killed vaccination was given at 5th day (ND and IB). I think this is ILT problem but I'm not sure about it. Mycoplasma galisepticum and synovi are negative. What can I do? Please, help me.

Recommend
Reply
Mustafa Ezat
Mustafa Ezat
17 de julio de 2018

I totally agree with you. Attenuated live ILT vaccine (CEO) can be transmitted to low immunity chicken or unvaccinated chicken lead to vaccinal laryngotracheitis infection, and also have severe vaccine reaction but you can use live vaccine tissue culture, which has a low vaccine reaction.
About usage vector ILT vaccine, I have some comment about it , immunity and protection against ILT mainly cellular immunity not humoral immunity vector vaccine induce cellular immunity or not some scientific article about vector ILT vaccine will provide 35 % protection in high challenge area but if you like to maximize protection should be give booster dose to achieve 80% protection.

Thanks,
Dr. Mustafa Ezat
Poultry Health Division Head.

Recommend
Reply
1
Profile picture
Would you like to discuss another topic? Create a new post to engage with experts in the community.
Featured users in Poultry Industry
Manuel Da Costa
Manuel Da Costa
Cargill
United States
Shivaram Rao
Shivaram Rao
Pilgrim´s
PhD Director Principal de Nutrición y Servicios Técnicos de Pilgrim’s Pride Corporation
United States
Karen Christensen
Karen Christensen
Tyson
Tyson
PhD, senior director of animal welfare at Tyson Foods
United States
Join Engormix and be part of the largest agribusiness social network in the world.